logo
Select company
Select metric
-42.97%Return on Assets
VS
Market
15
Sector
45
Industry
59
History
50
$ 2.27Close
$ 1.66 - $ 12.28 52-Week Range
Ticker Information

Ticker

IOVA

Company Name

IOVANCE BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IOVANCE BIOTHERAPEUTICS INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IOVA - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 907.44M$ -389.92M-42.97%
3/31/2025$ 966.74M$ -375.36M-38.83%
12/31/2024$ 910.43M$ -372.18M-40.88%
9/30/2024$ 991.12M$ -410M-41.37%
6/30/2024$ 964.32M$ -440.22M-45.65%
3/31/2024$ 869.83M$ -449.64M-51.69%
12/31/2023$ 780.35M$ -444.04M-56.9%
9/30/2023$ 852.32M$ -432.98M-50.8%
6/30/2023$ 757.29M$ -418.83M-55.31%
3/31/2023$ 824.77M$ -411.66M-49.91%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IOVANCE BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -32.56%.
  • Over the past 5 years, IOVANCE BIOTHERAPEUTICS INC's average ROA has been -46.73%.
  • The median ROA for IOVANCE BIOTHERAPEUTICS INC during this period was -44.84%
  • IOVANCE BIOTHERAPEUTICS INC reached its highest ROA over the past 5 years at -32.56%.
  • The lowest ROA recorded by IOVANCE BIOTHERAPEUTICS INC in the same timeframe -71.42%

IOVANCE BIOTHERAPEUTICS INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
XERS : XERIS BIOPHARMA HOLDINGS INC -9.56%RCUS : ARCUS BIOSCIENCES INC -27.72%DNA : GINKGO BIOWORKS HOLDINGS INC -25.6%AKBA : AKEBIA THERAPEUTICS INC -10.56%AUPH : AURINIA PHARMACEUTICALS INC 12.07%MNKD : MANNKIND CORP 7.97%GERN : GERON CORP -15.85%STOK : STOKE THERAPEUTICS INC 13.65%KROS : KEROS THERAPEUTICS INC 2.48%DAWN : DAY ONE BIOPHARMACEUTICALS INC -18.3%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for IOVANCE BIOTHERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -254.75M ] / Assets [ $ 782.29M ]
(=) ROA [ -32.56% ]

IOVA - Return on Assets, Last 5 years

-71.42%

Minimum

Sep 30, 2022

-32.56%

Maximum

Sep 30, 2020

-46.73%

Average

-44.84%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.07% with a standard deviation of 10.68%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.45K
min-33.51%
max33.98%
average0.07%
median1.52%
std10.68%